Bayer has a unique opportunity for startups to join Bayer Pharma's Co.Lab Cambridge incubator program in Cambridge, Massachusetts. Co.Lab Cambridge allows early stage life science startups to have access to state-of-the-art facilities, resources, and expertise with no strings attached in the world renowned biotech capital of the world. The program is open to applications from startups based in all countries. Interested applicants can start their application here

Areas of interest Bayer is interested in startups focused on:

• Cell therapy
• Gene therapy
• Gene delivery
• RNA therapeutics
• Oncology – small molecules/biologics/novel modalities
• Oncology – novel targets
• Autoimmune disease therapeutics